11:05 AM EST, 11/10/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts opened the week higher late Monday morning, rising 0.77% to 1,603.65 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies Cellectis ( CLLS ) and Genfit ( GNFT ) , which climbed 12.2% and 7.2% respectively. They were followed by 3D printer company Materialise (MTLS) and lender Banco Bilbao Vizcaya Argentaria ( BBVA ) , which advanced 4.8% and 2.4% respectively.

The decliners from continental Europe were led by petroleum refiner Equinor ( EQNR ) and telecommunications operator Telefonica ( TEF ) , which fell 2.2% and 1.4% respectively. They were followed by consumer goods giant Unilever ( UL ) and telecommunications company Ericsson (ERIC), which were down 1% and 0.8% respectively.

From the UK and Ireland, the gainers were led by alcoholic beverage company Diageo ( DEO ) and biotech firm Autolus Therapeutics ( AUTL ) , which rose 4.9% and 2.2% respectively. They were followed by pharmaceutical company AstraZeneca ( AZN ) and biopharmaceutical company Amarin ( AMRN ) , which were up 1.6% and 0.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which dropped 6% and 4.4% respectively. They were followed by software firm Endava ( DAVA ) and pharmaceutical company Silence Therapeutics ( SLN ) , which lost 3% and 1.2% respectively.